Selected research
Industry Research
Digital Metabolic Syndrome Management Industry Research Report 2026
Market perspective
The global Digital Metabolic Syndrome Management market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Digital Metabolic Syndrome Management market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Digital Metabolic Syndrome Management market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Digital Metabolic Syndrome Management market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Digital Metabolic Syndrome Management include Abbott Diabetes Care, Dexcom Inc, Vida Health, Oviva AG, CureApp Inc, Liva Healthcare, Welldoc Inc, Lark Health and Welby Inc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Digital Metabolic Syndrome Management market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Digital Metabolic Syndrome Management.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Digital Metabolic Syndrome Management Market by Company
Abbott Diabetes Care
Dexcom Inc
Vida Health
Oviva AG
CureApp Inc
Liva Healthcare
Welldoc Inc
Lark Health
Welby Inc
Hims & Hers Health
WW International
Yidu Tech
Ping An Healthcare
Teladoc Health
Omada Health
Virta Health
Digital Metabolic Syndrome Management Segment by Type
Diabetes Management
Obesity Management
Cardiovascular Risk Management
Fatty Liver and Metabolic Liver Disease Management
Digital Metabolic Syndrome Management Segment by Application
Home-Based Health Management
Hospital-Based Chronic Disease Management
Corporate Employee Health Management
Elderly Health Management
Insurance and Health Service Management
Others
Digital Metabolic Syndrome Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Metabolic Syndrome Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Metabolic Syndrome Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Metabolic Syndrome Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Digital Metabolic Syndrome Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Diabetes Management
- Obesity Management
- Cardiovascular Risk Management
- Fatty Liver and Metabolic Liver Disease Management
Applications
- Home-Based Health Management
- Hospital-Based Chronic Disease Management
- Corporate Employee Health Management
- Elderly Health Management
- Insurance and Health Service Management
- Others
Companies covered
- Abbott Diabetes Care
- Dexcom Inc
- Vida Health
- Oviva AG
- CureApp Inc
- Liva Healthcare
- Welldoc Inc
- Lark Health
- Welby Inc
- Hims & Hers Health
- WW International
- Yidu Tech
- Ping An Healthcare
- Teladoc Health
- Omada Health
- Virta Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Digital Metabolic Syndrome Management by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Diabetes Management
- 2.2.3 Obesity Management
- 2.2.4 Cardiovascular Risk Management
- 2.2.5 Fatty Liver and Metabolic Liver Disease Management
- 2.3 Digital Metabolic Syndrome Management by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Home-Based Health Management
- 2.3.3 Hospital-Based Chronic Disease Management
- 2.3.4 Corporate Employee Health Management
- 2.3.5 Elderly Health Management
- 2.3.6 Insurance and Health Service Management
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Digital Metabolic Syndrome Management Breakdown Data by Type
- 3.1 Global Digital Metabolic Syndrome Management Historic Market Size by Type (2021-2026)
- 3.2 Global Digital Metabolic Syndrome Management Forecasted Market Size by Type (2027-2032)
4 Digital Metabolic Syndrome Management Breakdown Data by Application
- 4.1 Global Digital Metabolic Syndrome Management Historic Market Size by Application (2021-2026)
- 4.2 Global Digital Metabolic Syndrome Management Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Digital Metabolic Syndrome Management Market Perspective (2021-2032)
- 5.2 Global Digital Metabolic Syndrome Management Growth Trends by Region
- 5.2.1 Global Digital Metabolic Syndrome Management Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Digital Metabolic Syndrome Management Historic Market Size by Region (2021-2026)
- 5.2.3 Digital Metabolic Syndrome Management Forecasted Market Size by Region (2027-2032)
- 5.3 Digital Metabolic Syndrome Management Market Dynamics
- 5.3.1 Digital Metabolic Syndrome Management Industry Trends
- 5.3.2 Digital Metabolic Syndrome Management Market Drivers
- 5.3.3 Digital Metabolic Syndrome Management Market Challenges
- 5.3.4 Digital Metabolic Syndrome Management Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Digital Metabolic Syndrome Management Players by Revenue
- 6.1.1 Global Top Digital Metabolic Syndrome Management Players by Revenue (2021-2026)
- 6.1.2 Global Digital Metabolic Syndrome Management Revenue Market Share by Players (2021-2026)
- 6.2 Global Digital Metabolic Syndrome Management Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Digital Metabolic Syndrome Management Head Office and Area Served
- 6.4 Global Digital Metabolic Syndrome Management Players, Product Type & Application
- 6.5 Global Digital Metabolic Syndrome Management Manufacturers Established Date
- 6.6 Global Digital Metabolic Syndrome Management Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Digital Metabolic Syndrome Management Market Size (2021-2032)
- 7.2 North America Digital Metabolic Syndrome Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Digital Metabolic Syndrome Management Market Size by Country (2021-2026)
- 7.4 North America Digital Metabolic Syndrome Management Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Digital Metabolic Syndrome Management Market Size (2021-2032)
- 8.2 Europe Digital Metabolic Syndrome Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Digital Metabolic Syndrome Management Market Size by Country (2021-2026)
- 8.4 Europe Digital Metabolic Syndrome Management Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Metabolic Syndrome Management Market Size (2021-2032)
- 9.2 Asia-Pacific Digital Metabolic Syndrome Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Digital Metabolic Syndrome Management Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Digital Metabolic Syndrome Management Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Digital Metabolic Syndrome Management Market Size (2021-2032)
- 10.2 South America Digital Metabolic Syndrome Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Digital Metabolic Syndrome Management Market Size by Country (2021-2026)
- 10.4 South America Digital Metabolic Syndrome Management Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Metabolic Syndrome Management Market Size (2021-2032)
- 11.2 Middle East & Africa Digital Metabolic Syndrome Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Digital Metabolic Syndrome Management Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Digital Metabolic Syndrome Management Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott Diabetes Care
- 12.1.1 Abbott Diabetes Care Company Information
- 12.1.2 Abbott Diabetes Care Business Overview
- 12.1.3 Abbott Diabetes Care Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.1.4 Abbott Diabetes Care Digital Metabolic Syndrome Management Product Portfolio
- 12.1.5 Abbott Diabetes Care Recent Developments
- 12.2 Dexcom Inc
- 12.2.1 Dexcom Inc Company Information
- 12.2.2 Dexcom Inc Business Overview
- 12.2.3 Dexcom Inc Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.2.4 Dexcom Inc Digital Metabolic Syndrome Management Product Portfolio
- 12.2.5 Dexcom Inc Recent Developments
- 12.3 Vida Health
- 12.3.1 Vida Health Company Information
- 12.3.2 Vida Health Business Overview
- 12.3.3 Vida Health Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.3.4 Vida Health Digital Metabolic Syndrome Management Product Portfolio
- 12.3.5 Vida Health Recent Developments
- 12.4 Oviva AG
- 12.4.1 Oviva AG Company Information
- 12.4.2 Oviva AG Business Overview
- 12.4.3 Oviva AG Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.4.4 Oviva AG Digital Metabolic Syndrome Management Product Portfolio
- 12.4.5 Oviva AG Recent Developments
- 12.5 CureApp Inc
- 12.5.1 CureApp Inc Company Information
- 12.5.2 CureApp Inc Business Overview
- 12.5.3 CureApp Inc Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.5.4 CureApp Inc Digital Metabolic Syndrome Management Product Portfolio
- 12.5.5 CureApp Inc Recent Developments
- 12.6 Liva Healthcare
- 12.6.1 Liva Healthcare Company Information
- 12.6.2 Liva Healthcare Business Overview
- 12.6.3 Liva Healthcare Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.6.4 Liva Healthcare Digital Metabolic Syndrome Management Product Portfolio
- 12.6.5 Liva Healthcare Recent Developments
- 12.7 Welldoc Inc
- 12.7.1 Welldoc Inc Company Information
- 12.7.2 Welldoc Inc Business Overview
- 12.7.3 Welldoc Inc Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.7.4 Welldoc Inc Digital Metabolic Syndrome Management Product Portfolio
- 12.7.5 Welldoc Inc Recent Developments
- 12.8 Lark Health
- 12.8.1 Lark Health Company Information
- 12.8.2 Lark Health Business Overview
- 12.8.3 Lark Health Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.8.4 Lark Health Digital Metabolic Syndrome Management Product Portfolio
- 12.8.5 Lark Health Recent Developments
- 12.9 Welby Inc
- 12.9.1 Welby Inc Company Information
- 12.9.2 Welby Inc Business Overview
- 12.9.3 Welby Inc Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.9.4 Welby Inc Digital Metabolic Syndrome Management Product Portfolio
- 12.9.5 Welby Inc Recent Developments
- 12.10 Hims & Hers Health
- 12.10.1 Hims & Hers Health Company Information
- 12.10.2 Hims & Hers Health Business Overview
- 12.10.3 Hims & Hers Health Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.10.4 Hims & Hers Health Digital Metabolic Syndrome Management Product Portfolio
- 12.10.5 Hims & Hers Health Recent Developments
- 12.11 WW International
- 12.11.1 WW International Company Information
- 12.11.2 WW International Business Overview
- 12.11.3 WW International Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.11.4 WW International Digital Metabolic Syndrome Management Product Portfolio
- 12.11.5 WW International Recent Developments
- 12.12 Yidu Tech
- 12.12.1 Yidu Tech Company Information
- 12.12.2 Yidu Tech Business Overview
- 12.12.3 Yidu Tech Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.12.4 Yidu Tech Digital Metabolic Syndrome Management Product Portfolio
- 12.12.5 Yidu Tech Recent Developments
- 12.13 Ping An Healthcare
- 12.13.1 Ping An Healthcare Company Information
- 12.13.2 Ping An Healthcare Business Overview
- 12.13.3 Ping An Healthcare Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.13.4 Ping An Healthcare Digital Metabolic Syndrome Management Product Portfolio
- 12.13.5 Ping An Healthcare Recent Developments
- 12.14 Teladoc Health
- 12.14.1 Teladoc Health Company Information
- 12.14.2 Teladoc Health Business Overview
- 12.14.3 Teladoc Health Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.14.4 Teladoc Health Digital Metabolic Syndrome Management Product Portfolio
- 12.14.5 Teladoc Health Recent Developments
- 12.15 Omada Health
- 12.15.1 Omada Health Company Information
- 12.15.2 Omada Health Business Overview
- 12.15.3 Omada Health Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.15.4 Omada Health Digital Metabolic Syndrome Management Product Portfolio
- 12.15.5 Omada Health Recent Developments
- 12.16 Virta Health
- 12.16.1 Virta Health Company Information
- 12.16.2 Virta Health Business Overview
- 12.16.3 Virta Health Revenue in Digital Metabolic Syndrome Management Business (2021-2026)
- 12.16.4 Virta Health Digital Metabolic Syndrome Management Product Portfolio
- 12.16.5 Virta Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst